Clinical Trial Update: Effects of Acipimox on Mitochondrial Function in Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating acipimox effects on mitochondrial function in obesity; results have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity
• Hypertriglyceridemia
• Insulin Resistance

Drugs mentioned

• Acipimox (Acipimox)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Abdominal Obesity, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2016-02-03